The Australian health care system supports management of T1D through provision of free needles and syringes with a subsidy to insulin and consumables (eg glucose monitoring strips and pump supplies) with a copayment through the Pharmaceutical Benefits Scheme and National Diabetes Subsidy Scheme respectively. The gene discussed is INS; the disease is type 1 diabetes mellitus.